Lower Risks of New-Onset Hepatocellular Carcinoma in Patients With Type 2 Diabetes Mellitus Treated With SGLT2 Inhibitors Versus DPP4 Inhibitors
Oscar Hou In Chou(University of Hong Kong), Jiandong Zhou(University of Hong Kong), Helen Huang(University College Hospital), Edward Christopher Dee(Memorial Sloan Kettering Cancer Center), Nancy Kwan Man(University of Hong Kong), Gary M. Tse(Second Hospital of Tianjin Medical University), Apichat Kaewdech(Prince of Songkla University), Ariel Ka-Man Chow(Metropolitan University), Fengshi Jing(Guangdong Provincial People's Hospital), Tong Liu(Second Hospital of Tianjin Medical University), Jing Ning(Dalian Medical University), Raymond Chan, Cheuk To Chung, Sharen Lee(University of Oxford), Bernard Man Yung Cheung(Chinese University of Hong Kong), Kenrick Ng(University College Hospital)
Cited by 24
Related Papers
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
|Cell stem cell|2021|311
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170